Stephen M. Condon
Keine laufenden Positionen mehr
Karriereverlauf von Stephen M. Condon
Ehemalige bekannte Positionen von Stephen M. Condon
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Corporate Officer/Principal | 01.01.2000 | 01.01.2000 |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Corporate Officer/Principal | - | - |
| TETRALOGIC PHARMACEUTICALS CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2004 | - |
| Corporate Officer/Principal | 01.05.2004 | - |
Ausbildung von Stephen M. Condon
| University of Pennsylvania | Doctorate Degree |
| University of Massachusetts | Undergraduate Degree |
| University of Georgia | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Frankreich | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 3 |
| Process Industries | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TETRALOGIC PHARMACEUTICALS CORPORATION | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
Rhone Poulenc Rorer
Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Process Industries |
- Börse
- Insiders
- Stephen M. Condon
- Erfahrung
